Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus

Dermatology

Volumn 210, Issue 3, 2005, Pages 229-232

  Fricain, J C ^a,b   Sibaud, V ^c   Campana, F ^a   Lepreux, S ^b   Taieb A ^c  

^a UFR Odontologie   (France)

^b HÔPITAL PELLEGRIN   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Lichen planus, oral; Pigmentation, mucosal; Tacrolimus

Indexed keywords

TACROLIMUS;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; MELANOCYTE; MELANOGENESIS; PRIORITY JOURNAL; SIDE EFFECT; SKIN PIGMENTATION;

ADMINISTRATION, CUTANEOUS; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MOUTH DISEASES; MOUTH MUCOSA; TACROLIMUS;

EID: 17244373498     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083516     Document Type: Article

References (14)

1. Cribier B, Frances C, Chosidow O: Treatment of lichen planus: An evidence based medicine analysis of efficacy. Arch Dermatol 1998;134: 1521-1530.
2. Vente C, Reich K, Rupprecht R, Neuman C: Erosive mucosal lichen planus: Response to topical treatment with tacrolimus. Br J Dermatol 1999;140:338-342.
3. Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR: Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35-41.
4. Morrison L, Kratochvil J, Gorman A: An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002;47:617-620.
5. Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil R, Ortonne JP: Treatment of chronic erosive oral lichen planus with low concentration of topical tacrolimus. Arch Dermatol 2002;138:1135-1138.
6. Rozycki TW, Rogers RS, Pittezkow MR, Evoy MT, David MDP: Topical tacrolimus in the treatment of symptomatic oral lichen planus: A series of 13 patients. J Am Acad Dermatol 2002;46:27-34.
7. Shen J, Peduis-Leftick A: Mucosal staining after using topical tacrolimus to treat erosive oral lichen planus. J Am Acad Dermatol 2004;50: 326.
8. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM: Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44:858-864.
9. Freeman AK, Linowski GJ, Brady C, Lind L, Vanveldhuisen P, Singer G, et al: Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003;48:564-568.
10. Richter-Hintz D, Schuppe HC, Homey B, Lehmann P, Ruzicka T: Topical tacrolimus is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000;42:304-305.
11. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB: A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003;139:581-585.
12. Hodgson TA, Sahni N, Kaliakatsou F, Buchanan JA, Porter SR: Long-term efficacity and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus. Eur J Dermatol 2003;13:466-470.
13. Vemoto S, Tanaka K, Tokunaga Y: Long-term use of FK 506 in living related liver transplantation. Transplant Int 1994;7:S81-S84.
14. Brunetel L, Le Gall F, Delaval Y, Sixou JL, Dabadie A, Bonnaure-Mallet M: An unusual oral chronic graft versus host disease like syndrome following a liver transplant. J Periodontol 2003;74:352-356.